EFNB2 and breast carcinoma: For instance, TNYL-RAW has been recently used to demonstrate that ephrin-B2 has effects in endothelial cells that are independent of interaction with EphB4 [37] and that EphB4 has effects in breast cancer cells that are independent of interaction with ephrin-B2 [67].